Offer - Urjas Oil for just ₹ 1 X
Loxapac 25 Capsule is a prescription medicine that is available as a Capsule. It is primarily used for the treatment of Schizophrenia.
Medical history of the patient along with age and gender determines the dosage of Loxapac 25 Capsule. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Loxapac 25 Capsule as well, which are listed below. Normally, these side effects of Loxapac 25 Capsule are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Loxapac 25 Capsule is Moderate for pregnant women and Severe for women who are breastfeeding. In addition, Loxapac 25 Capsule's effects on the liver, heart and kidney are discussed below in the Loxapac 25 Capsule related warnings section.
Loxapac 25 Capsule can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Loxapac 25 Capsule in conditions like Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Heart Disease. Other conditions have been mentioned below in the Loxapac 25 Capsule contraindications section.
Besides this, Loxapac 25 Capsule may also have severe interaction with some medicines. See below for a complete list.
You should also be aware that Loxapac 25 Capsule is not safe while driving, and is not addiction.
Loxapac 25 Capsule is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Loxapac 25 Capsule safe for pregnant women?
Loxapac may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Loxapac again without your doctor's advice.
Is the use of Loxapac 25 Capsule safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Loxapac. It should only be taken after medical advice.
What is the effect of Loxapac 25 Capsule on the Kidneys?
Loxapac rarely harms the kidneys.
What is the effect of Loxapac 25 Capsule on the Liver?
Loxapac has very mild side effects on the liver.
What is the effect of Loxapac 25 Capsule on the Heart?
Loxapac is rarely harmful for the heart.
Loxapac 25 Capsule should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Loxapac 25 Capsule unless your doctor advises you to do so -
Is this Loxapac 25 Capsule habit forming or addictive?
Loxapac 25 Capsule is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Loxapac 25 Capsule can make you feel drowsy.
Is it safe?
Yes, but take Loxapac 25 Capsule only as per medical advice.
Is it able to treat mental disorders?
Loxapac 25 Capsule has been seen to have positive effect on patients with mental disorders.
Interaction between Food and Loxapac 25 Capsule
Loxapac 25 Capsule may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Loxapac 25 Capsule
Consuming Loxapac 25 Capsule with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Loxitane® (Loxapine Succinate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 440,441